Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.

doi:10.1002/ijc.29295

PMID: 25348852DOI: 10.1002/ijc.29295Oct 29, 2014Paper

Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.

International Journal of Cancer. Journal International Du Cancer

Yin CaoE Giovannucci

Abstract

Insulin-like growth factor (IGF)-1 is associated with a higher risk of prostate cancer. IGF-binding protein (IGFBP)-1, a marker for insulin activity, also binds IGF-1 and inhibits its action. Data on IGFBP-1 and prostate cancer risk are sparse and whether the IGF and insulin axes interact to affect prostate cancer carcinogenesis is unknown. We evaluated the independent and joint influence of prediagnostic plasma levels of IGFBP-1 (fasting) and IGF-1 on risk of prostate cancer among 957 cases and 1,021 controls with fasting levels of IGFBP-1 and 1,709 cases and 1,778 controls with IGF-1 nested within the Health Professionals Follow-up Study. Unconditional logistic regression adjusting for matching factors was used to estimate the odds ratio (OR) and 95% confidence interval (CI). Higher prediagnostic fasting IGFBP-1 levels were associated with lower risk of prostate cancer (highest vs. lowest quartile OR = 0.67, 95% CI 0.52-0.86, p(trend) = 0.003), which remained similar after adjusting for IGF-1. Prediagnostic IGF-1 was associated with increased risk of prostate cancer (highest vs. lowest quartile OR = 1.28, 95% CI = 1.05-1.56, p(trend) = 0.01). The associations with each marker were primarily driven by lower-grade and non-advan...Continue Reading

References

Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study

Jun 1, 1990·American Journal of Epidemiology·E B RimmW C Willett

Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence

Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J I JonesD R Clemmons

Effect of short-term fasting on free/dissociable insulin-like growth factor I concentrations in normal human serum

Dec 1, 1996·The Journal of Clinical Endocrinology and Metabolism·A BereketC H Lang

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions

Dec 31, 1997·Endocrine Reviews·S RajaramS Mohan

Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells

Apr 9, 1999·Journal of Molecular Endocrinology·C M PerksJ M Holly

Insulin-like growth factor-binding protein-1 and prostate cancer

Nov 24, 1999·Journal of the National Cancer Institute·L B SignorelloH O Adami

Lifestyle factors and insulin-like growth factor 1 levels among elderly men

Aug 23, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·L B SignorelloH O Adami

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

Dec 7, 2000·Journal of the National Cancer Institute·P StattinR Kaaks

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

May 17, 2001·Journal of the National Cancer Institute·A W HsingF Z Stanczyk

A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China

Oct 27, 2001·Epidemiology·L ZhongF Jin

Focal adhesion kinase (FAK) regulates insulin-stimulated glycogen synthesis in hepatocytes

Jan 26, 2002·The Journal of Biological Chemistry·Danshan HuangMichael Bryer-Ash

IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms

Oct 16, 2002·The Journal of Endocrinology·S Mohan, D J Baylink

Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth

Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·Eero KajantieJohan Eriksson

Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women

Apr 24, 2003·Cancer Causes & Control : CCC·Naomi E AllenTimothy J Key

Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival

May 15, 2003·Endocrinology·Tung H NgoWilliam J Aronson

Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging

Feb 20, 2004·Urology·J Slade HubbardElizabeth A Platz

Insulin-like growth factors and neoplasia

Jul 2, 2004·Nature Reviews. Cancer·Michael N PollakSusan E Hankinson

Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin

Nov 13, 2004·Cancer·Chu ChenNoel S Weiss

Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States)

Sep 1, 2005·Cancer Causes & Control : CCC·Libby M MorimotoJohn D Potter

Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden

Feb 6, 2007·International Journal of Cancer. Journal International Du Cancer·Tanja StocksPär Stattin

Prediagnostic C-peptide and risk of prostate cancer

Oct 13, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marilyn J BorugianRichard P Gallagher

Determination of blood pressure percentiles in normal-weight children: some methodological issues

Jan 31, 2008·American Journal of Epidemiology·B RosnerB Falkner

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.

Oct 8, 2008·Annals of Internal Medicine·Andrew W RoddamPilar Galan

Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.

Jan 15, 2009·International Journal of Cancer. Journal International Du Cancer·Mari-Anne RowlandsRichard M Martin

IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

Apr 8, 2009·Trends in Endocrinology and Metabolism : TEM·Stephen B Wheatcroft, Mark T Kearney

Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer.

Aug 25, 2009·Journal of the National Cancer Institute·Demetrius AlbanesJarmo Virtamo

Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort.

Feb 19, 2010·The Prostate·Jasmeet K GillLaurence N Kolonel

Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004.

May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Katharina NimptschEdward Giovannucci

Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study

Sep 23, 2010·Cancer Prevention Research·Gabriel Y LaiElizabeth A Platz

Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT.

Nov 23, 2011·Cancer Research·Mari-Anne RowlandsRichard M Martin

Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer

Dec 21, 2011·Cancer Causes & Control : CCC·Mari-Anne RowlandsRichard M Martin

Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition.

Jul 5, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alison J PriceTimothy Key

Insulin-like growth factors (IGFs) and IGF-binding proteins in active monitoring of localized prostate cancer: a population-based observational study.

Oct 23, 2012·Cancer Causes & Control : CCC·Mari-Anne RowlandsRichard M Martin

Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study

Mar 26, 2014·Cancer Causes & Control : CCC·Gabriel Y LaiElizabeth A Platz

Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival

May 16, 2014·Journal of the National Cancer Institute·Yin CaoJing Ma

❮ Previous

Next ❯

Citations

Milk--A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation

Aug 1, 2015·International Journal of Molecular Sciences·Bodo C Melnik

Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease

Nov 4, 2015·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Halina GrosmanGabriela Berg

IGF-binding protein 2 is a candidate target of therapeutic potential in cancer

Dec 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiaofeng YaoLun Zhang

Physiology and pathophysiology of IGFBP-1 and IGFBP-2 - consensus and dissent on metabolic control and malignant potential

Nov 3, 2015·Best Practice & Research. Clinical Endocrinology & Metabolism·Andreas Hoeflich, Vincenzo C Russo

Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk.

Aug 15, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jian-Qin ZhangBin-Wu Sheng

Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents

Aug 25, 2015·Chemico-biological Interactions·Gaurav JoshiRaj Kumar

Persistent androgen receptor addiction in castration-resistant prostate cancer.

Nov 15, 2015·Journal of Hematology & Oncology·Michael T Schweizer, Evan Y Yu

The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research

Jun 16, 2016·Cell Metabolism·Sofiya MilmanNir Barzilai

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.

May 27, 2016·International Journal of Cancer. Journal International Du Cancer·Carolina BonillaJeff M P Holly

WITHDRAWN: Emodin increases expression of insulin-like growth factor binding protein 1 through activation of MEK/ERK/AMPKα and interaction of PPARγ and Sp1 in lung cancer

Sep 13, 2016·Biochimica Et Biophysica Acta·Qing TangSwei Sunny Hann

Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer

May 26, 2017·International Journal of Cancer. Journal International Du Cancer·Barbra A DickermanKathryn M Wilson

Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease

Aug 31, 2018·Carcinogenesis·Thomas U AhearnUNKNOWN Transdisciplinary Prostate Cancer Partnership (ToPCaP)

Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study

Oct 24, 2018·Oncotarget·Céline LavaletteFlorence Menegaux

Body mass index trajectories and prostate cancer risk: Results from the EPICAP study.

Jul 9, 2020·Cancer Medicine·Céline LavaletteFlorence Menegaux

Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-κB

Jun 18, 2016·International Journal of Molecular Medicine·Shuang WuOsamu Yokosuka

Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma

Feb 2, 2017·BMC Cancer·Xinwei FengGe Zhang

Investigation of the molecular mechanisms underlying postoperative recurrence in prostate cancer by gene expression profiling

Feb 6, 2018·Experimental and Therapeutic Medicine·Cheng YajunXu Bin

Preliminary investigation of blood concentrations of insulin-like growth factor, insulin, lactate and β-hydroxybutyrate in dogs with lymphoma as compared with matched controls

Dec 6, 2017·Veterinary and Comparative Oncology·B McQuownC R Heinze

Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer

Apr 29, 2016·Molecular Medicine Reports·Wojciech KwasniewskiJan Kotarski

Evaluating serum insulin-like growth factor 1 and insulin-like growth factor binding protein 3 as markers in prostate cancer diagnosis

Mar 10, 2016·The International Journal of Biological Markers·Giulia RainatoMassimo Gion

Association between serum levels of insulin-like growth factor-1, bioavailable testosterone, and pathologic Gleason score

Jul 12, 2018·Cancer Medicine·Myong KimHanjong Ahn

Using Supervised Learning Methods for Gene Selection in RNA-Seq Case-Control Studies

Aug 21, 2018·Frontiers in Genetics·Stephane Wenric, Ruhollah Shemirani

Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A/BIM signaling in a double-transgenic mouse model

Jul 18, 2019·Oncogene·Shuang WangYingjie Wu

Inactivation of Stat3 and crosstalk of miRNA155-5p and FOXO3a contribute to the induction of IGFBP1 expression by beta-elemene in human lung cancer.

Sep 14, 2018·Experimental & Molecular Medicine·Fang ZhengSwei Sunny Hann

The Continuing Evolution of Insulin-like Growth Factor Signaling

Apr 1, 2020·F1000Research·Steven A Rosenzweig

IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells

Jul 14, 2020·Oncotarget·Rehanna MansorClaire Perks

The Role of Actin Dynamics and Actin-Binding Proteins Expression in Epithelial-to-Mesenchymal Transition and Its Association with Cancer Progression and Evaluation of Possible Therapeutic Targets

Mar 28, 2018·BioMed Research International·Magdalena IzdebskaMaciej Gagat

Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk

Jul 25, 2019·Cancer Research·Lang WuUNKNOWN PRACTICAL, CRUK, BPC3, CAPS, PEGASUS Consortia

Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate Cancer.

Jan 11, 2021·European Urology·Benjamin C FuLorelei A Mucci

Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo.

Dec 10, 2020·Cancers·Yanrong QianJohn J Kopchick

Endurance Exercise Mitigates Immunometabolic Adipose Tissue Disturbances in Cancer and Obesity.

Dec 30, 2020·International Journal of Molecular Sciences·José Cesar Rosa-Neto, Loreana Sanches Silveira

Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche.

Mar 5, 2021·Journal of Biomedical Science·T OllewagenC Smith

Association of Anthropometric Measures With the Risk of Prostate Cancer in the Multiethnic Cohort.

Mar 23, 2021·American Journal of Epidemiology·Olivia SattayapiwatChristopher A Haiman

Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.

Sep 22, 2021·Aging·Yihong WangJisheng Liu

❮ Previous

Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.